Coronavirus disease (COVID-19) outbreak

Roche’s antibody test receives FDA Emergency Use Authorization

The Elecsys® Anti-SARS-CoV-2 immunoassay can help determine if a patient has been exposed to the virus which causes COVID-19 and if the patient has developed antibodies against SARS-CoV-2.

Find Testing Sites


We stand in solidarity
What we challenge, we change. Roche stands with the Black community against racism, violence and injustice.


Stay up to date on Roche’s response to COVID-19 (Coronavirus)

Access helpful resources such as customer communications, fact sheets, frequently asked questions, testing information and follow along with our blog.

Learn more


Real-time RT-PCR test

Detecting SARS-CoV-2 in currently infected patients with high sensitivity

The cobas® SARS-CoV-2 for use on the cobas® 6800/8800 Systems is a real-time RT-PCR test intended for the qualitative detection of nucleic acids from SARS-CoV-2 in clinician-instructed self-collected nasal swab specimens (collected on site), and clinician-collected nasal, nasopharyngeal, and oropharyngeal swab specimens from patients.

cobas® SARS-CoV-2 Test